Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Apr 16;22(7):1290–1298. doi: 10.1016/j.bbmt.2016.04.009

Table 3.

Patient Outcomes

Number (%), or
Median (Range)
Engraftment (%) 20 (100)
  Chimerism (%) Full donor 11 (55)
Mixed 9 (45)
  Time (days) Neutrophil 12 (5 – 23)
Plt 13.5 (7 – 34)
aGVH (max) Gr 1 3 (15)
Gr 2 5 (25)
Gr 3 2 (10)
cGVH 6 (30)
Final cause of death Sepsis 1 (5)
Relapse 12 (60)
GVH 3 (15)
Survival (days) Overall 233 (8-2,251)
Relapse-free 102 (8-2,251)
GVH- and Relapse-free 89 (8-343)

Reported as % of 20 evaluable patients